Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment

Journal of Glaucoma

Volumn 22, Issue 3, 2013, Pages 250-254

  Sakata, Rei ^a   Aihara, Makoto ^a   Murata, Hiroshi ^b   Mayama, Chihiro ^a   Tomidokoro, Atsuo ^a   Iwase, Aiko ^d   Araie, Makoto ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c Mutual Aid Association of Public School Teachers   (Japan)

^d Tajimi Iwase Eye Clinic   (Japan)

Author keywords

Field defect progression; Linear mixed model; Myopic refraction; Normal tension glaucoma

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARTICLE; CENTRAL CORNEAL THICKNESS; DISEASE COURSE; EYE REFRACTION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MYOPIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; VISUAL FIELD; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MYOPIA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 84874933950     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31823298fb     Document Type: Article

References (60)

1. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 2nd ed. Savona: European Glaucoma Society; 2003.
2. Shields M. Textbook of Glaucoma. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2005.
3. Leskea MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the early manifest glaucoma trial. Curr Opin Ophthalmol. 2004;15: 102-106. (Pubitemid 38457128)
4. Heijl A, Bengtsson B, Hyman L, et al. Natural history of openangle glaucoma. Ophthalmology. 2009;116: 2271-2276.
5. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121: 48-56. (Pubitemid 36401765)
6. Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999;106: 2010-2015.
7. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 714-720; discussion 829-730. (Pubitemid 34620349)
8. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126: 487-497.
9. Hart WM Jr, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982;89: 268-279. (Pubitemid 12143090)
10. Phelps CD, S H, Montague PR. Visual field in low-tension glaucoma, primary open-angle glaucoma, and anterior ischemic optic neuropathy. Doc Ophthalmol Proc Ser. 1983;35: 113-124.
11. Mayama C, Suzuki Y, Araie M, et al. Myopia and advancedstage open-angle glaucoma. Ophthalmology. 2002;109: 2072-2077.
12. Weber J, Schultze T, Ulrich H. The visual field in advanced glaucoma. Int Ophthalmol. 1989;13: 47-50. (Pubitemid 19142263)
13. Kawano J, Tomidokoro A, Mayama C, et al. Correlation between hemifield visual field damage and corresponding parapapillary atrophy in normal-tension glaucoma. Am J Ophthalmol. 2006;142: 40-45.
14. Zeiter JH, Shin DH. Diabetes in primary open-angle glaucoma patients with inferior visual field defects. Graefes Arch Clin Exp Ophthalmol. 1994;232: 205-210. (Pubitemid 24127406)
15. Suzuki Y, Kitazawa Y, Araie M, et al. Mathematical and optimal clustering of test points of the central 30-degree visual field of glaucoma. J Glaucoma. 2001;10: 121-128. (Pubitemid 32298242)
16. King D, Drance SM, Douglas G, et al. Comparison of visual field defects in normal-tension glaucoma and high-tension glaucoma. Am J Ophthalmol. 1986;101: 204-207. (Pubitemid 16136578)
17. Chihara E, Tanihara H. Parameters associated with papillomacular bundle defects in glaucoma. Graefes Arch Clin Exp Ophthalmol. 1992;230: 511-517.
18. Araie M, Yamagami J, Suziki Y. Visual field defects in normaltension and high-tension glaucoma. Ophthalmology. 1993;100: 1808-1814. (Pubitemid 24004602)
19. Samuelson TW, Spaeth GL. Focal and diffuse visual field defects: their relationship to intraocular pressure. Ophthalmic Surg. 1993;24: 519-525. (Pubitemid 23246338)
20. Araie M. Pattern of visual field defects in normal-tension and high-tension glaucoma. Curr Opin Ophthalmol. 1995;6: 36-45.
21. Koseki N, Araie M, Suzuki Y, et al. Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes. Jpn J Ophthalmol. 1995;39: 274-283.
22. Araie M, Arai M, Koseki N, et al. Influence of myopic refraction on visual field defects in normal tension and primary open angle glaucoma. Jpn J Ophthalmol. 1995;39: 60-64.
23. Nelson P, Aspinall P, Papasouliotis O, et al. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12: 139-150. (Pubitemid 36427702)
24. Sumi I, Shirato S, Matsumoto S, et al. The relationship between visual disability and visual field in patients with glaucoma. Ophthalmology. 2003;110: 332-339. (Pubitemid 36187438)
25. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16: 2349-2380. (Pubitemid 27458250)
26. Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics. An introduction to hierarchical linear modelling. Stat Med. 1999;18: 855-888. (Pubitemid 29154551)
27. Shigeeda T, Tomidokoro A, Araie M, et al. Long-term followup of visual field progression after trabeculectomy in progressive normal-tension glaucoma. Ophthalmology. 2002. 109: 766-770. (Pubitemid 34270137)
28. Drance SM. Disc hemorrhages in the glaucomas. Surv Ophthalmol. 1989;33: 331-337. (Pubitemid 19113489)
29. Suzuki Y, Iwase A, Araie M, et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology. 2006;113: 1613-1617. (Pubitemid 44292321)
30. Suzuki Y, Araie M, Ohashi Y. Sectorization of the central 3. degrees visual field in glaucoma. Ophthalmology. 1993;100: 69-75. (Pubitemid 23041133)
31. R Foundation for Statistical Computing. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
32. Pinheiro J, Bates D, DebRoy S, et al. R Development Core Team. nlme: Linear and Nonlinear Mixed Effects Models. R Package Version 3.1-96. Vienna, Austria: R Foundation for Statistical Computing; 2009.
33. Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108: 247-253. (Pubitemid 32115951)
34. Tomita G, Araie M, Kitazawa Y, et al. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye (Lond). 2004;18: 984-989. (Pubitemid 39430034)
35. Araie M, Shirato S, Yamazaki Y, et al. Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, doublemasked comparative study. Jpn J Ophthalmol. 2008;52: 255-264.
36. Wong TY, Klein BE, Klein R, et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology. 2003;110: 211-217. (Pubitemid 36068747)
37. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120: 1268-1279. (Pubitemid 36105431)
38. Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma. 2005;14: 135-138. (Pubitemid 40389182)
39. Chihara E, Liu X, Dong J, et al. Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma. Ophthalmologica. 1997;211: 66-71. (Pubitemid 27102239)
40. Perdicchi A, Iester M, Scuderi G, et al. Visual field damage and progression in glaucomatous myopic eyes. Eur J Ophthalmol. 2007;17: 534-537. (Pubitemid 47605760)
41. Phelps CD. Effect of myopia on prognosis in treated primary open-angle glaucoma. Am J Ophthalmol. 1982;93: 622-628. (Pubitemid 12107413)
42. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131: 699-708. (Pubitemid 32522638)
43. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998;7: 372-377. (Pubitemid 30247081)
44. Sohn SW, Song JS, Kee C. Influence of the extent of myopia on the progression of normal-tension glaucoma. Am J Ophthalmol. 2010;149: 831-838.
45. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111: 1641-1648. (Pubitemid 39179676)
46. Sawada A, Tomidokoro A, Araie M, et al. Refractive errors in an elderly Japanese population: the Tajimi study. Ophthalmology. 2008;115: 363-370, e363.
47. Bengtsson B, Leske MC, Yang Z, et al. Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology. 2008;115: 2044-2048.
48. Ishida K, Yamamoto T, Sugiyama K, et al. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol. 2000;129: 707-714. (Pubitemid 30604147)
49. Kim YD, Han SB, Park KH, et al. Risk factors associated with optic disc haemorrhage in patients with normal tension glaucoma. Eye (Lond). 2010;24: 567-572.
50. Anderson DR, Drance SM, Schulzer M. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol. 2003;136: 820-829. (Pubitemid 37330024)
51. Leske MC, Wu SY, Hennis A, et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115: 85-93. (Pubitemid 350309410)
52. Araie M, Sekine M, Suzuki Y, et al. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology. 1994;101: 1440-1444. (Pubitemid 24319293)
53. Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 2000;130: 274-279.
54. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115: 1123-1129, e1123.
55. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol. 2007;125: 1010-1013. (Pubitemid 47258028)
56. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114: 205-209. (Pubitemid 46161799)
57. Caprioli J. Intraocular pressure fluctuation; an independent risk factor for glaucoma? Arch Ophthalmol. 2007;125: 1124-1125. (Pubitemid 47258048)
58. Jonas JB, Stroux A, Velten I, et al. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci. 2005;46: 1269-1274. (Pubitemid 41685863)
59. Medeiros FA, Sample PA, Zangwill LM, et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003;136: 805-813. (Pubitemid 37330022)
60. Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology. 2006;113: 1354-1362.